Karl-Erik Andersson to Phosphodiesterase Inhibitors
This is a "connection" page, showing publications Karl-Erik Andersson has written about Phosphodiesterase Inhibitors.
Connection Strength
0.870
-
Werkström V, Hedlund P, Lee T, Andersson KE. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder. BJU Int. 2009 Dec; 104(11):1740-5.
Score: 0.306
-
Andersson KE, Uckert S, Stief C, Hedlund P. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn. 2007 Oct; 26(6 Suppl):928-33.
Score: 0.269
-
Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol. 2009 Jul; 19(4):380-94.
Score: 0.076
-
Zhao W, Sato Y, Melman A, Andersson KE, Christ G. Metrics for evaluation of age-related changes in erectile capacity in a rodent model. J Sex Med. 2009 Jul; 6(7):1885-92.
Score: 0.075
-
Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol. 2006 Dec; 50(6):1194-207; discussion 1207.
Score: 0.061
-
Küthe A, Montorsi F, Andersson KE, Stief CG. Phosphodiesterase inhibitors for the treatment of erectile dysfunction. Curr Opin Investig Drugs. 2002 Oct; 3(10):1489-95.
Score: 0.048
-
Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010 Jan; 7(1 Pt 2):445-75.
Score: 0.020
-
Werkström V, Svensson A, Andersson KE, Hedlund P. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int. 2006 Aug; 98(2):414-23.
Score: 0.015